Submissions that propose amendments that have previously been voted on by the Commission shall be considered to be petitions and not supplementary submissions and are subject to the policies and procedures for petitions set forth herein. The Commission will consider only those petitions and supplementary submissions that are received by the Drug Control Program on time. Consideration of petitions or supporting documents from petitioners that are not received on time will be deferred until a later Commission meeting. Supplementary submissions, including written responses, documents from responding parties, or supplementary documents from petitioners, that are not received on time cannot be considered at the meeting at which the petition will be considered. Such submissions will be included in the public comment period, if held, or any subsequent meetings at which the petition is considered.
All documents submitted are public records.
Public Records Law requests are fulfilled upon payment of a reimbursement fee to cover the costs incurred by the Commonwealth. The Drug Control Program will forward to the Drug Formulary Commission all petitions, supplementary submissions, and related documents submitted in accordance with the policies and procedures herein not less than two weeks prior to the Commission meeting at which such petitions will be considered. The preliminary agenda for the meeting will be available to the public, upon request, not less than two weeks prior to the meeting. The Commission will meet in public to review petitions and supplementary submissions, hear oral statements, at its discretion, and make recommendations to the Department concerning the disposition of petitions. If the Department proposes an amendment of the MLID a public comment period will be held.